Former President and Chief Executive Officer · Enliven Therapeutics, Inc. (ELVN)

Sam Kintz

A named executive officer of Enliven Therapeutics in every fiscal year CompBrief holds from FY2022 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$8,908,647

Salary $624,154Stock awards $0

FY2024: $5,461,660

2nd of 4 named executive officers at Enliven Therapeutics by FY2025 total.

4 named officers on file for Enliven Therapeutics, FY2025

Sam Kintz’s pay file — $29

  • 4 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Enliven Therapeutics’s whole pay program stands against its peers

  • Enliven Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ELVN→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2026 (DEF 14A).

Free

Get Sam Kintz’s full pay file as a PDF — free

More than this page: up to 10 years of Sam’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Sam Kintz compensation by year

Enliven Therapeutics Summary Compensation Table · all 4 fiscal years held
In US dollars, as Enliven Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2023FY2024FY2025
Salary$400,000$561,190$600,000$624,154
Bonus$0$0$0$0
Stock awards$0$0$0$0
Option awards$126,839$7,413,342$4,487,860$7,952,553
Non-equity incentive$195,000$302,500$360,000$316,800
Pension and deferred compensation$0$0$0$0
All other$2,000$2,719$13,800$15,140
Total$723,839$8,279,751$5,461,660$8,908,647

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Enliven Therapeutics, Inc. DEF 14A filed April 27, 2026, accession 0001193125-26-182045, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Enliven Therapeutics, Inc. filed document, accession 0001193125-26-182045. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2026.

$724K
$8.3M
$5.5M
$8.9M
FY22
FY23
FY24
FY25
SalaryNon-equity incentiveOption awardsAll other

Enliven Therapeutics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Richard FairPresident and Chief Executive Officer$11,918,926
Sam Kintz · this pageFormer President and Chief Executive Officer$8,908,647
Helen CollinsChief Medical Officer$3,501,699
Ben HohlChief Financial Officer$3,443,173

Board service

Enliven Therapeutics board · FY2023

How this board is paid

Company policy: Enliven Therapeutics pays directors a $35,000 cash retainer and $250,000 in Options. As stated in Enliven Therapeutics's FY2023 proxy.

The full Enliven Therapeutics compensation record

free company brief

This page is one person within Enliven Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Enliven Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Sam Kintz's compensation dossier · One-time report. No refunds.